E&S HEALTHCARE
LIVE

Serial Number

90031610

Owner

E&S Healthcare Co., Ltd.

Attorney

Max Vern

Filing Date

Jul 1, 2020

Add to watchlist:

No watchlists yet
View on USPTO

E&S HEALTHCARE Trademark

Serial Number: 90031610 • Registration: 7602896

E&S HEALTHCARE is a trademark filed by E&S Healthcare Co., Ltd. on July 1, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

E&S Healthcare Co., Ltd. (5 trademarks)

42, Gukjegwahak 11-ro,

Entity Type: 98

Trademark Details

Filing Date

July 1, 2020

Registration Date

December 17, 2024

Published for Opposition

September 10, 2024

Goods & Services

Diagnostic reagents for medical use for immune disease; diagnostic reagents for medical use; medical diagnostic reagents; diagnostic reagents for medical or veterinary purposes; immunoassay diagnostic reagents for medical purposes; biological reagents for medical purposes, biological reagents for medical diagnostic purposes; reagents for medical diagnostic purposes for the analysis of body fluids; reagent paper for medical purposes; medicated lozenges; chemical reagents for medical purposes; diagnostic reagents for medicinal use; clinical medical reagents; clinical diagnostic reagents in the nature of clinical medical reagents

Medical device for detecting cancer; medical device, namely, in vitro diagnostic medical device for detecting breast cancer by Thioredoxin 1(Trx1) expression level; medical device for breast cancer detection for medical use, namely breast cancer diagnostic kit comprised of serum collection empty enzyme-linked immunosorbent assay (ELISA) plate for medical purposes,, anti-Thioredoxin 1(Trx 1) antibody coated 96-well plate, Trx 1 calibrator and anti-Trx 1 detection antibody; medical diagnostic apparatus for detecting cancer and testing for viruses; apparatus for blood testing for medical use; medical device and apparatus in the field of clinical diagnosis, namely, a breast cancer diagnostic kit comprised of serum collection empty enzyme-linked immunosorbent assay (ELISA) plate for medical purposes, antiThioredoxin 1(Trx 1) antibody coated 96-well plate, Trx 1 calibrator and anti-Trx 1 detection antibody; testing instruments for medical diagnostic purposes, namely, a breast cancer diagnostic kit comprised of serum collection empty enzyme-linked immunosorbent assay (ELISA) plate for medical purposes, anti-Thioredoxin 1(Trx 1) antibody coated 96-well plate, Trx 1 calibrator and anti-Trx 1 detection antibody; tools for medical diagnostics, namely, a breast cancer diagnostic kit comprised of serum collection empty enzyme-linked immunosorbent assay (ELISA) plate for medical purposes, anti-Thioredoxin 1(Trx 1) antibody coated 96-well plate, Trx 1 calibrator and anti-Trx 1 detection antibody; medical diagnostic apparatus, analytical apparatus for medical purposes and blood pressure measuring apparatus; blood analysis apparatus for diagnosis.

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Dec 17, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Dec 17, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 10, 2024 NPUB
PUBLISHED FOR OPPOSITION
Sep 10, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 21, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 8, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Aug 8, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 8, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Aug 8, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 8, 2024 CNEA
NOTIFICATION OF FINAL REFUSAL EMAILED
May 8, 2024 GNFN
FINAL REFUSAL E-MAILED
May 8, 2024 GNFR
FINAL REFUSAL WRITTEN
May 8, 2024 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 27, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 27, 2024 CRFA
NOTICE OF REVIVAL - E-MAILED
Mar 26, 2024 NREV
PETITION GRANTED - RESPONSE RECEIVED
Mar 26, 2024 PGRR
ASSIGNED TO PETITION STAFF
Mar 26, 2024 APET
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 22, 2024 TROA
TEAS PETITION TO REVIVE RECEIVED
Feb 22, 2024 PROA
ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Jan 23, 2024 MAB2
ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Jan 23, 2024 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Jan 23, 2024 ABN2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Sep 26, 2023 GNS2
INQUIRY TO SUSPENSION E-MAILED
Sep 26, 2023 GNSI
SUSPENSION INQUIRY WRITTEN
Sep 26, 2023 CNSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Mar 10, 2023 GNS3
LETTER OF SUSPENSION E-MAILED
Mar 10, 2023 GNSL
SUSPENSION LETTER WRITTEN
Mar 10, 2023 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 9, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 9, 2023 CRFA
ASSIGNED TO LIE
Mar 9, 2023 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Mar 2, 2023 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Dec 5, 2022 GNS2
INQUIRY TO SUSPENSION E-MAILED
Dec 5, 2022 GNSI
SUSPENSION INQUIRY WRITTEN
Dec 5, 2022 CNSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
May 10, 2022 GNS3
LETTER OF SUSPENSION E-MAILED
May 10, 2022 GNSL
SUSPENSION LETTER WRITTEN
May 10, 2022 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 21, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 21, 2022 CRFA
ASSIGNED TO LIE
Apr 18, 2022 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Apr 14, 2022 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Oct 14, 2021 GNS2
INQUIRY TO SUSPENSION E-MAILED
Oct 14, 2021 GNSI
SUSPENSION INQUIRY WRITTEN
Oct 14, 2021 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Oct 13, 2021 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Mar 26, 2021 GNS3
LETTER OF SUSPENSION E-MAILED
Mar 26, 2021 GNSL
SUSPENSION LETTER WRITTEN
Mar 26, 2021 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 9, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 8, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 8, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 13, 2020 GNRN
NON-FINAL ACTION E-MAILED
Oct 13, 2020 GNRT
NON-FINAL ACTION WRITTEN
Oct 13, 2020 CNRT
ASSIGNED TO EXAMINER
Oct 6, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 29, 2020 NWOS
NEW APPLICATION ENTERED
Jul 4, 2020 NWAP